Clinical and pathological factors predictive of bladder cancer recurrence in patients with upper tract primary TCC

Basit Öğe Kaydı
dc.authoridYoldaş, Mehmet/0000-0001-5031-0435
dc.authorscopusid55169033600
dc.authorscopusid56340743800
dc.authorscopusid35622851900
dc.authorwosidYoldaş, Mehmet/ABQ-3471-2022
dc.contributor.authorYoldas, M.
dc.contributor.authorTurk, H.
dc.contributor.authorYoldas, T. K.
dc.date.accessioned2023-01-12T20:16:22Z
dc.date.available2023-01-12T20:16:22Z
dc.date.issued2021
dc.departmentN/A/Departmenten_US
dc.description.abstractObjective: To evaluate predictive clinical and histopathological risk factors for bladder cancer recurrence in patients who underwent nephroureterectomy for primary upper urinary tract transitional cell carcinoma (TCC). Subjects and Methods: Data of 111 patients, who were diagnosed with upper urinary tract TCC and underwent nephroureterectomy were reviewed A total of 65 patients were included in the study, after excluding 34 patients. Results: Bladder cancer recurrence developed in 20 (30.7%) of the 65 patients under evaluation. The recurrence-free survival rates in the 1st, 3rd, and 5th years were 78.4%, 70.7% and 69.2%, respectively. Lymphovascular invasion and a positive surgical margin were defined as risk factors for bladder cancer recurrence. In addition, patients with multiple tumors and low stage and grade pathology had a high rate of bladder cancer recurrence, although this was not statistically significant. Conclusion: After nephroureterectomy, a careful follow-up is required in terms of bladder tumor recurrence especially in patients with a positive surgical margin, lymphovascular invasion, low-grade tumors, or multifocal tumors.en_US
dc.identifier.doi10.4103/njcp.njcp_503_19
dc.identifier.endpage777en_US
dc.identifier.issn1119-3077
dc.identifier.issue5en_US
dc.identifier.pmid34018989en_US
dc.identifier.scopus2-s2.0-85106738341en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage774en_US
dc.identifier.urihttps://doi.org/10.4103/njcp.njcp_503_19
dc.identifier.urihttps://hdl.handle.net/11454/78703
dc.identifier.volume24en_US
dc.identifier.wosWOS:000657358400020en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofNigerian Journal of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBladder cancer recurrenceen_US
dc.subjectnephroureterectomyen_US
dc.subjectupper urinary tracten_US
dc.subjectUpper Urinary-Tracten_US
dc.subjectTransitional-Cell-Carcinomaen_US
dc.subjectIntravesical Recurrenceen_US
dc.subjectUrothelial Carcinomaen_US
dc.subjectRisk-Factorsen_US
dc.subjectLaparoscopic Nephroureterectomyen_US
dc.subjectPrognostic Variablesen_US
dc.subjectOncological Outcomesen_US
dc.subjectSurgical-Managementen_US
dc.subjectTumorsen_US
dc.titleClinical and pathological factors predictive of bladder cancer recurrence in patients with upper tract primary TCCen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu